家族性高胆固醇血症与中国队列中的胸腺衰老
在562例杂合子家族性高胆固醇血症(FH)患者和295例年龄匹配健康对照中,未治疗FH患者胸腺输出减少,胸腺衰老提前约6年,他汀治疗者部分保留CD4+近期胸腺 emigrants水平。
要点
- 未治疗FH患者胸腺输出显著降低,尤其18-30岁或携带高致病性LDLR变异者。
- FH患者胸腺衰老提前约6年,CD4+ RTE中位百分比更早达到健康对照水平。
- 他汀治疗的FH患者,尤其女性,循环CD4+ RTE水平高于未治疗者。
核心结论
- 高胆固醇血症与胸腺输出减少相关,他汀治疗患者部分保留循环CD4+ RTE水平,支持代谢与免疫综合管理策略。
研究设计与样本
- 研究纳入562例杂合子FH患者(236例未治疗,326例接受降脂治疗)和295例年龄匹配健康对照,采用流式细胞术检测CD4+ RTE,并分析T细胞受体 excision circles和T细胞受体β测序。
主要发现
- 与健康对照相比,未治疗FH患者naïve CD4+ T细胞中CD4+ RTE百分比显著降低,尤其在18-30岁或携带高致病性LDLR变异者。
- T细胞受体 excision circle分析支持CD4+和CD8+ naïve T细胞胸腺输出减少。
- FH患者达到健康对照的中位CD4+ RTE百分比约提前6年(男性:19.12 vs 25.51岁;女性:19.18 vs 25.58岁)。
- FH患者显示T细胞受体β克隆向高频克隆倾斜。
- 他汀治疗的FH患者,尤其女性,循环CD4+ RTE水平高于未治疗FH患者。
临床怎么用
- 对FH患者,除降脂外应关注免疫衰老,他汀治疗可能部分保留胸腺输出。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Lifelong exposure to elevated low-density lipoprotein cholesterol in familial hypercholesterolaemia (FH) patients not only increases the risk of atherosclerotic cardiovascular disease, but also affects other organs beyond the cardiovascular system. In a large FH cohort, this study investigated the effects of hypercholesterolaemia on the thymic output and explored whether lipid-lowering therapy can reverse these effects. METHODS: According to the Dutch Lipid Clinic Network criteria, 562 heterozygous FH patients (236 treatment-naïve, 326 on lipid-lowering therapy) and 295 age-matched healthy controls (HCs) were enrolled. Thymic output was measured by circulating CD4+ recent thymic emigrants (RTEs) with flow cytometry, and T-cell receptor excision circles in sorted naïve CD4+ and CD8+ T cells. Repertoire diversity and clonal expansion were evaluated by T-cell receptor beta sequencing. RESULTS: Compared with HCs, treatment-naïve FH patients displayed a significantly reduced percentage of CD4+ RTE among naïve CD4+ T cells, particularly in those aged 18-30 years or carrying highly pathogenic LDLR variants. T-cell receptor excision circle analysis supported reduced thymic output in both CD4+ and CD8+ naïve T cells. Quantified thymic ageing further showed that FH patients reached the median CD4+ RTE percentage of HCs ∼6 years earlier (males: 19.12 vs 25.51 years; females: 19.18 vs 25.58 years). Consistent with reduced thymic output, FH patients showed skewing towards high-frequency T-cell receptor beta clones. Statin-treated FH patients, particularly females, showed higher circulating CD4+ RTE levels than statin-naïve FH patients. CONCLUSIONS: Hypercholesterolaemia was associated with reduced thymic output, while statin-treated patients showed partially preserved circulating CD4+ RTE levels, supporting integrated metabolic and immunologic strategies for FH management.
引用
- Li F, Zhang J, Deng J, et al. Familial hypercholesterolaemia and thymic ageing in a Chinese cohort. Eur Heart J. 2026. PMID: 42900678. doi:10.1093/eurheartj/ehag810
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。